Explore key perspectives in the development of psychedelic treatments through insights from a Randomized Clinical Trial with Psilocybin to treat Depression 🍄

Starting with how factors like set and setting shape the subjective experience experience and treatment outcomes. Delve into the complexities of designing clinical trials, including the challenges posed by blinding and the nocebo effect, and the ethical implications for psychedelic drug development.

Finally, learnings from the study offer a glimpse into the future of psychedelic-assisted therapy (PAT), highlighting its potential in group therapy settings and the promise of precision psychiatry for tailored treatment approaches.